Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Milestone
17
Sep 09, 2010 01:12PM
1
Sep 09, 2010 02:38PM
2
Sep 09, 2010 02:39PM
7
Sep 09, 2010 05:09PM
6
Sep 09, 2010 07:28PM
1
Sep 09, 2010 07:45PM
7
Sep 09, 2010 09:58PM
4
Sep 09, 2010 09:59PM

Why did you try to disprove my factual statements by omitting the very point I was trying to make?:

b. Accelerated filers

We are considering as an additional element of the proposed rule, and seek comment on, whether proposed Exchange Act Rule 14a-11 should apply only to those companies that are subject to accelerated deadlines for filing Exchange Act periodic reports,64 and investment companies registered under Section 8 of the Investment Company Act.65 Companies that fall within the definition of "accelerated filer" in Exchange Act Rule 12b-266 would be subject to the security holder nomination procedure for any fiscal year in which they must file all of their periodic reports on an accelerated basis. Accordingly, the security holder nomination procedure would apply to a company after it first meets the following conditions as of the end of its fiscal year:

  • The company's common equity public float was $75 million or more as of the last business day of its most recently completed second fiscal quarter;

How is telling Mr Lozano the following "doing things right"?

You have a big chance for getting on the director nomination ballot, if SEC rules on this proposal

.

.

.

Be well

1
Sep 09, 2010 10:33PM
6
Sep 09, 2010 10:42PM
Share
New Message
Please login to post a reply